197 related articles for article (PubMed ID: 36201246)
1. RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer.
Deng P; Wang Z; Chen J; Liu S; Yao X; Liu S; Liu L; Yu Z; Huang Y; Xiong Z; Xiao R; Gao J; Liang W; Chen J; Liu H; Hong JH; Chan JY; Guan P; Chen J; Wang Y; Yin J; Li J; Zheng M; Zhang C; Zhou P; Kang T; Teh BT; Yu Q; Zuo Z; Jiang Q; Liu J; Xiong Y; Xia X; Tan J
J Clin Invest; 2022 Nov; 132(22):. PubMed ID: 36201246
[TBL] [Abstract][Full Text] [Related]
2. Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers.
Yan M; Xu H; Waddell N; Shield-Artin K; Haviv I; ; McKay MJ; Fox SB
Breast Cancer Res; 2012 Apr; 14(2):R69. PubMed ID: 22537934
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the interaction between the cohesin subunits Rad21 and SA1/2.
Zhang N; Jiang Y; Mao Q; Demeler B; Tao YJ; Pati D
PLoS One; 2013; 8(7):e69458. PubMed ID: 23874961
[TBL] [Abstract][Full Text] [Related]
4. Reduced cohesin destabilizes high-level gene amplification by disrupting pre-replication complex bindings in human cancers with chromosomal instability.
Yun J; Song SH; Kang JY; Park J; Kim HP; Han SW; Kim TY
Nucleic Acids Res; 2016 Jan; 44(2):558-72. PubMed ID: 26420833
[TBL] [Abstract][Full Text] [Related]
5. Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers.
Xu H; Yan M; Patra J; Natrajan R; Yan Y; Swagemakers S; Tomaszewski JM; Verschoor S; Millar EK; van der Spek P; Reis-Filho JS; Ramsay RG; O'Toole SA; McNeil CM; Sutherland RL; McKay MJ; Fox SB
Breast Cancer Res; 2011 Jan; 13(1):R9. PubMed ID: 21255398
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA Meg3 Regulates Mafa Expression in Mouse Beta Cells by Inactivating Rad21, Smc3 or Sin3α.
Wang N; Zhu Y; Xie M; Wang L; Jin F; Li Y; Yuan Q; De W
Cell Physiol Biochem; 2018; 45(5):2031-2043. PubMed ID: 29529600
[TBL] [Abstract][Full Text] [Related]
7. Separase, securin and Rad21 in neural cell growth.
Pemberton HN; Franklyn JA; Boelaert K; Chan SY; Kim DS; Kim C; Cheng SY; Kilby MD; McCabe CJ
J Cell Physiol; 2007 Oct; 213(1):45-53. PubMed ID: 17450531
[TBL] [Abstract][Full Text] [Related]
8. Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer.
Sprooten J; Vankerckhoven A; Vanmeerbeek I; Borras DM; Berckmans Y; Wouters R; Laureano RS; Baert T; Boon L; Landolfo C; Testa AC; Fischerova D; Van Holsbeke C; Bourne T; Chiappa V; Froyman W; Schols D; Agostinis P; Timmerman D; Tejpar S; Vergote I; Coosemans A; Garg AD
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34795003
[TBL] [Abstract][Full Text] [Related]
9. RAD21 cooperates with pluripotency transcription factors in the maintenance of embryonic stem cell identity.
Nitzsche A; Paszkowski-Rogacz M; Matarese F; Janssen-Megens EM; Hubner NC; Schulz H; de Vries I; Ding L; Huebner N; Mann M; Stunnenberg HG; Buchholz F
PLoS One; 2011 May; 6(5):e19470. PubMed ID: 21589869
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of cancer drivers reveals cohesin and CTCF as suppressors of PD-L1.
Oreskovic E; Wheeler EC; Mengwasser KE; Fujimura E; Martin TD; Tothova Z; Elledge SJ
Proc Natl Acad Sci U S A; 2022 Feb; 119(7):. PubMed ID: 35149558
[TBL] [Abstract][Full Text] [Related]
11. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner.
Liu Y; Wang G; Yang Y; Mei Z; Liang Z; Cui A; Wu T; Liu CY; Cui L
Oncogene; 2016 May; 35(21):2789-800. PubMed ID: 26387538
[TBL] [Abstract][Full Text] [Related]
12. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1.
Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X
Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539
[TBL] [Abstract][Full Text] [Related]
13. Cohesin subunit RAD21: From biology to disease.
Cheng H; Zhang N; Pati D
Gene; 2020 Oct; 758():144966. PubMed ID: 32687945
[TBL] [Abstract][Full Text] [Related]
14. The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass.
Nishioka N; Inoue K; Adachi K; Kiyonari H; Ota M; Ralston A; Yabuta N; Hirahara S; Stephenson RO; Ogonuki N; Makita R; Kurihara H; Morin-Kensicki EM; Nojima H; Rossant J; Nakao K; Niwa H; Sasaki H
Dev Cell; 2009 Mar; 16(3):398-410. PubMed ID: 19289085
[TBL] [Abstract][Full Text] [Related]
15. Cohesin is required for activation of MYC by estradiol.
McEwan MV; Eccles MR; Horsfield JA
PLoS One; 2012; 7(11):e49160. PubMed ID: 23145106
[TBL] [Abstract][Full Text] [Related]
16. Suppression of RAD21 gene expression decreases cell growth and enhances cytotoxicity of etoposide and bleomycin in human breast cancer cells.
Atienza JM; Roth RB; Rosette C; Smylie KJ; Kammerer S; Rehbock J; Ekblom J; Denissenko MF
Mol Cancer Ther; 2005 Mar; 4(3):361-8. PubMed ID: 15767545
[TBL] [Abstract][Full Text] [Related]
17. RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas.
Deb S; Xu H; Tuynman J; George J; Yan Y; Li J; Ward RL; Mortensen N; Hawkins NJ; McKay MJ; Ramsay RG; Fox SB
Br J Cancer; 2014 Mar; 110(6):1606-13. PubMed ID: 24548858
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of YAP recognition by TEAD4 in the hippo pathway.
Chen L; Chan SW; Zhang X; Walsh M; Lim CJ; Hong W; Song H
Genes Dev; 2010 Feb; 24(3):290-300. PubMed ID: 20123908
[TBL] [Abstract][Full Text] [Related]
19. Calpain-1 cleaves Rad21 to promote sister chromatid separation.
Panigrahi AK; Zhang N; Mao Q; Pati D
Mol Cell Biol; 2011 Nov; 31(21):4335-47. PubMed ID: 21876002
[TBL] [Abstract][Full Text] [Related]
20. A splicing isoform of TEAD4 attenuates the Hippo-YAP signalling to inhibit tumour proliferation.
Qi Y; Yu J; Han W; Fan X; Qian H; Wei H; Tsai YH; Zhao J; Zhang W; Liu Q; Meng S; Wang Y; Wang Z
Nat Commun; 2016 Jun; 7():ncomms11840. PubMed ID: 27291620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
